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Abstract 
Simultaneous identification of messenger RNA 
(mRNA) and proteins in the same cells or tissues is a 
valuable tool to help the cell biologist evaluate the cell 
secretory cycle. Some cells may produce the mRNA and 
delay the production of the proteins. Alternatively, the 
proteins may be rapidly secreted. Other cells may 
produce both in sequence within the same time frame. 
Because of this difference, some cells can only be 
identified by their mRNA product. Others may have 
both products. This presentation describes a non-
radioactive approach to the detection of both products 
with dual-peroxidase labeling protocols in use in this 
laboratory since 1983. The first detection system uses 
biotinylated cRNA probes or oligoprobes in in situ 
hybridization along with antisera to biotin to detect the 
hybrid. The detection system is amplified by 2-3 layers 
of anti-biotin, second antibody (made against the anti-
biotin) and streptavidin conjugated to horseradish 
peroxidase. After the mRNA is detected with a blue-
black substrate (nickel intensified diaminobenzidine), 
the antigens are detected with immunoperoxidase 
techniques and orange-amber substrate. The in situ 
hybridization protocol can also be used at the electron 
microscopic level. Trouble shooting and control proto-
cols are also described. This approach has been shown 
to be valuable for detection of pituitary hormones, 
growth factors mRNAs and antigens. 
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Hybridization refers to the reaction between two 
single-stranded nucleic acid molecules that bind by 
means of hydrogen bonding of complementary base 
pairs. Hybridization performed "in situ" refers to those 
techniques that allow binding and detection of hybrids in 
a cell or tissue section. 
Initially, in situ hybridization was performed to 
detect deoxyribonucleic acid (DNA) targets or amplified 
ribosomal ribonucleic acid (RNA genes) within cell 
nuclei (Gall and Pardue, 1969; John et al., 1969; 
Buorgiorno-Nardelli and Amaldi, 1970). Early research-
ers and clinicians have also mapped the location of genes 
within chromosomal preparations or nuclei (Pardue and 
Dawid, 1981; Foste! et al., 1984). The early uses ofin 
situ hybridization for cytoplasmic RNA involved detec-
tion of viral nucleic acid sequences within infected 
tissues (Brahic and Haase, 1978; Haase et al., 1981). 
Early investigators used radiolabeled complementary 
cDNA or cRNA probes for the hybridization reaction. 
Detection of the hybrids then involved autoradiography. 
However, during the past decade other detection systems 
have developed that can be as efficient as those with 
radioactive labels and take only a day or two to perform. 
Most of these involve the attachment of a signaling 
hapten molecule such as biotin or digoxygenin to the 
cDNA or cRNA probe. The detection systems for these 
molecules are enhanced by sandwich techniques that 
apply different layers of reactants, or enzyme reactions, 
or both. The techniques can be readily applied to the 
detection of both mRNA and antigens within the cells 
(by dual-labeling approaches). 
The purpose of this presentation will be to describe 
a method for the detection of mRNAs and antigens with 
dual-labeling immunocytochemistry (Childs et al., 1987, 
1990, 199la,b, 1994; Kaiser et al., 1992; Lee et al., 
1993; Fan et al., 1995). We use biotinylated comple-
mentary oligonucleotide or cRNA probes to hybridize 
with the cytoplasmic mRNAs. Then we detect the 
probes with anti-biotin and enhance the reaction by a 
sandwich technique that provides layers of biotin and 
streptavidin-peroxidase (McQuaid and Allan, 1992; Fan 
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et al., 1995). After the initial reaction, we can detect 
the pituitary antigens by classical immunoperoxidase 
cytochemistry with the use of a different colored sub-
strate (Childs et al., 1987, 1990, 1991a,b, 1994; Kaiser 
et al., 1992; Lee et al., 1993). 
Materials and Methods 
When we first detected mRNA hybrids in whole 
pituitary cells, we used the avidin biotin peroxidase 
complex technique (ABC Elite, Vector Laboratories, 
Burlingame, CA) (Childs et al., 1987, 1990, 199 la,b, 
1992a,b, 1994; Kaiser et al., 1992; Lee et al., 1993). 
We no longer use this complex to detect the biotinylated 
probes because we frequently encountered high back-
ground with ABC kits used from 1993 to the present. 
The early Elite kits did not have these background 
problems. Thus, we now use a new five-step immuno-
labeling protocol that detects biotin conjugated to the 
cRNA probes with anti-biotin. It was first described by 
McQuaid and Allan (1992). This protocol will be 
described in the following paragraphs. 
Preparation of pituitary cells 
To maximize our ability to detect mRNA and 
antigens, the protocol is applied to cells plated for 1-36 
h on 13 mm glass coverslips (Thomas Scientific, 
Suresdesboro, NJ; Catalog number 6672A 75) in 24 well 
trays (Fisher Scientific, Houston, TX; Catalog number 
08-757-156). The protocol can also be used on frozen 
sections or paraffin sections. The probes used for the 
hybridization are either cRNA probes (Childs et al., 
1987, 1990, 199la,b; Fan et al., 1995) or complementa-
ry oligonucleotide probes at least 30 mer long (Childs et 
al., 1992 a,b, 1994; Kaiser et al., 1992; Lee et al., 
1993). They may be biotinylated by the Vector Photo-
biotin kit (Vector Laboratories) following kit instructions 
(Childs et al., 1987; Wu et al., 1991, 1992). More 
recently, we have ordered the oligonucleotide probes 
commercially prepared, with Biotin attached. Alterna-
tively, we add Biotin-DTP to the cRNA probes produced 
during in vitro transcription (Fan et al., 1995). 
All fixation, washing, and handling methods are run 
under sterile conditions to prevent RNase contamination. 
The buffer or diluent solutions are made, Millipore 
filtered, and stored frozen in small aliquots. Controls 
include substitution of labeled sense sequences, or 
omission of the labeled probe. The protocol can be 
adapted for use with dispersed cells at the electron 
microscopic level. 
Preparation of solutions 
The following list includes the solutions needed for 
in situ hybridiz.ation. Table 1 provides information about 
some of the major vendors that supply these reagents. 
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(1) Phosphate buffered saline (PBS): 0.1 M phos-
phate buffer + 0.9% NaCl pH 7.2 
(2) Triton X-100 (0.3%): 300 µl Triton X-100 
(Sigma Chemical, St. Louis, MO); bring to 100 ml with 
0.1 M PBS. 
(3) EDTA (50 mM): add 1.46 g EDTA to 100 ml 
of 0.1 M Tris buffer (Sigma Chemical, Catalog number 
T-5030) (20 ml 0.5 M Tris + 80 ml Millipore-filtered 
water), pH 8.0. 
(4) Para-formaldehyde (4%): 4.0 g para-formalde-
hyde in 100 ml 0.1 M PBS, pH 7 .2. 
(5) Acetic anhydride (0.25 % ) + O. lM triethanol-
amine: 250 µl acetic anhydride; bring to 100 ml with 
Millipore filtered water, then add 1.856 g triethanol-
amine, pH 8.0 (Sigma Chemical) 
(6) Deionized formamide (50%) in 2X Sodium Salt 
Citrate (SSC): make a 1: 10 dilution from 20X SSC with 
Millipore-filtered water and add 1: 1 formamide (Sigma 
Chemical, Catalog number F-7503) 
(7) Sodium Salt Citrate Stock (SSC): make 20X 
SSC stock by adding 3 M sodium chloride + 0.3 M 
Sodium Citrate to Millipore filtered water. Make 4X 
solution with a 1:5 dilution from stock 20X SSC with 
Millipore filtered water 
Another task is to prepare the in situ hybridiz.ation 
buffer. The components are added in sequence in the 
following instructions. It usually takes about a day and 
it can be prepared in advance. Most of these compo-
nents come from Sigma Chemical, unless otherwise 
noted (see Table 1). 
(1) Deionize formamide: add 1.5 g REXYN 1-300 
(Fisher Scientific, Catalog number R-208) to 100 ml 
formamide, stir for 45-60 min, filter through Whatman 
filter paper. 
(2) Combine 100 ml deionized formamide + 100 ml 
4X SSC (20 ml 20X SSC + 80 ml Millipore filtered 
water). The final concentration will be 50% formamide. 
(3) Add 7.88 g Tris salt (0.25 M), pH 7.5, warm to 
about 37°C in 1.0 ml Millipore filtered water. Dissolve 
Tris. 
(4) With sterile syringe and needle, add the follow-
ing to the warm formamide-Tris solution: 20 g dextran 
sulfate; 0.5 g bovine serum albumin (RIA grade) (Sigma 
Chemical, Catalog number A-7638), 0.5 g Ficoll-400, 
0.5 g Polyvinyl pyrrolidone-360, 1.0 g sodium pyro-
phosphate, 1.0 g sodium lauryl sulfate. 
(5) Finally, add 200 µl of dissolved salmon sperm 
DNA (ssDNA) to 200 ml of hybridiz.ation buffer. 
(6) Aliquot into 10 ml units and store frozen (-
200C) in 15 ml centrifuge tubes 
Prehybridization protocol 
The next series of steps involve preparing the cells 
for the hybridiz.ation. Several components are used to 
Combined immunocytochemistry and in situ hybridization 
Table 1. Vendors for in situ hybridization histochemistry, including Uniform Resource Locator (URL, Internet link) 
Vendor Address Telephonenumber Internet 
DAKO Corporation 6392 Via Real, Carpenteria, CA 93013 800-235-5763 Dimensions has a web 
page devoted to DAKO 
Corporation (http:/ /www2. 
multinet.net/dli/dako.htm) 
which has access to data 
sheets 




P.O.Box 14848, Lenexa, KS 66325 
P.O.Box 14508; St. Louis, MO 63178 
800-255-6032 
800-325-3010 http://www. sigma. sial. 
com/sigma/sigma.html 
Thomas Scientific 99 High Hill Road, P.O.Box 99, 800-345-2100 
Suresdesboro, NJ 08085-0099 
Vector Laboratories 30 Ingold Road, Burlingame, CA 94010 800-227-6666 http: / /www2. mu! tin et. net/ 
dli/vector.htm 
Table 2. Internet Uniform Resource Locator (URL) links to courses, protocols and services in in situ hybridization 
(1) Link to our protocols including the colored versions of Fig. 1 and other photographs. We will continue to 
update this page as we progress. URL: http://cellbio.utmb.edu/childs/in _ situ.htm 
(2) The Anderson Laboratory in situ protocol (URL: http://www.cco.ca1tech.e ... r/htmls/Big_In_situ.html)describes 
non-radioactive methods for labeling frozen sections, whole mount embryos and cultured cells. 
(3) This protocol (URL: http://cellbio.ucdavis.e ... mePage/Tucker/WCRDB.html describes single cell RT-PCR and 
quantitative in situ hybridization for beginners. 
(4) Dr. Jan Blancato (ONCOR, Inc.) gives a course in in situ hybridization. The URL is: http://www.cua.edu/ 
www/catc/ish.htm 
(5) Exon-Intron, Inc. runs a course in in situ hybridization. The URL is: http://www.dnatech.com/insitu.htm. 
(6) Paul Hough at Brookhaven National Laboratory runs an advanced in situ hybridization course. The URL is 
http://www. cshl. org/ meetings/96si tu. htm. 
aid penetration and several steps are used to prevent 
non-specific reactions. In our protocol, the pituitary 
cells are plated on glass coverslips and grown in 
Dulbecco's Modified Eagle's Medium (DMEM, JRH 
Biosciences, Lenexa, KS; Catalog number 56499-lOL), 
and fixed in 2.5 % glutaraldehyde (in 0.1 M phosphate 
buffer) for 30 min at room temperature. Then cells are 
washed for 1 h in 4 changes of phosphate buffer + 
4.5 % sucrose. We work under sterile conditions even 
during the fixation process and store the cells no longer 
than 1 week at 2-4 °C. The steps are taken to prevent 
RNase contamination which would eliminate RNA from 
the tissue or cells. 
On the day of the hybridization, we first rinse the 
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fixed cells on coverlips with fresh, sterile 0.1 M phos-
phate buffered saline (PBS) for 5 min at room tempera-
ture, shaking. Then we treat in the following sequence 
of solutions. (All of the following chemicals but the p-
formaldehyde came from Sigma Chemical). All steps 
are done at room temperature. 
(1) To aid penetration of reagents, the cells are first 
treated with 0.3% Triton X-100 for 15 min at room 
temperature. This is followed by washing with O. lM 
PBS (twice, 3 min each, while gently shaking on a side-
to side shaker). 
(2) To further improve penetration and remove 
associated proteins, we next treat with Proteinase K (1 
µg/ml) for 15 min at room temperature. 
G.V. Childs 
(3) The cells are then stabilized by postfixation with 
4 % para-formaldehyde/0. lM PBS for 5 min at room 
temperature. This is followed by washing with 0.1 M 
PBS (twice, 3 min each, while gently shaking). 
(4) To cover non-specific reactive sites, we next 
treat the cells with 0.25 % acetic anhydride for 10 min 
while shaking. 
(5) We then treat the cells with 50% formamide/2X 
SSC for 10 min while shaking the tray at room tempera-
ture. Then we continue the incubation at 37°C for 10 
min. This solution prepares the cells for the hybridiza-
tion buffer and helps break weak hydrogen bonds in the 
non-specific linkages between the complementary probe 
and the surrounding tissue. If there is a 2-3 % mismatch 
in the complementary probe, the concentration of this 
solution should be lowered to 40-45% to prevent break-
ing bonds in the specific probe-mRNA hybrid. This 
lower concentration should also be used to make the 
hybridization buffer. (Note that the concentration in the 
buffer is 50 % in the above formulation). 
Alternative pre-hybridization technique 
We are currently testing pepsin digestion in lieu of 
the proteinase K and have had successful results with 
our cells fixed in either glutaraldehyde or para formalde-
hyde. The Pepsin is purchased from Sigma (Catalog 
number PN6887) and is made up just before use. Two 
mg of pepsin are added per ml of 0.01 N HCI. It is 
stored at room temperature for no longer than two 
hours. It is added to the cells for 25 min at 37°C 
followed by an additional 10 min at room temperature. 
Hybridization conditions 
The cells are then placed in the hybridization 
solutions which is 300 ng/ml of biotinylated oligonucle-
otide or cRNA-probe diluted in hybridization buffer (see 
above). They are incubated for 12-15 hat 37°C. The 
temperature of hybridization may be varied according to 
the melting temperature of the probe. We have found 
that a range from 36 to 42 C works for most of our 
probes against gonadotropins (Childs et al., 1987, 1992 
a,b) or pro-opiomelanotropin mRNAs (Wu et al., 1992). 
Post-hybridization protocol 
After the overnight hybridization the post-hybridiza-
tion washing steps are followed. We also add an RNase 
treatment step if the probe used was a cRNA (Childs et 
al., 1987; Fan et al., 1995). The coverslips are first 
washed with 4X SSC (three times, 15 min each; this is 
done at room temperature with gentle shaking during the 
last 5 min). This wash is at low enough stringency (high 
salt concentration) to remove the excess unreacted probe 
without removing the probe that has specifically hybrid-
ized to the mRNA. If there is background with the 
reaction, higher stringency washes can be done. Also, 
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one can raise the temperature of the washes. This 
involves continuing the washes with reduced concentra-
tions of SSC (2X, lX and 0.5X), 15 min each wash. 
However, we have found this to be unnecessary, espe-
cially with our oligonucleotide probes. 
Detection of the biotin 
After the post-hybridization washes, the detection 
protocol can be followed. 
The detection protocol begins with a blocking step in a 
solution containing proteins. They cover non-specific 
sites and prevent background reactions, but they do not 
react with any of the components of the detection 
protocol. Therefore, we first block with 0.05 M Tris 
buffered saline containing 1 % bovine serum albumin + 
10% normal horse serum (Vector Laboratories) for 15 
min at room temperature (pH 7 .6). Then we detect the 
biotin on the hybrids with the following sequence: 
(1) The cells are first treated with monoclonal anti-
biotin (1:30) (Dako Corp.) for 30 min at 37°C. They 
are then washed with 0.05 M Tris buffered saline 
(twice, for 3 min each), pH 7.6). 
(2) The cells are then incubated with biotinylated 
horse anti-mouse lgG (rat absorbed, Vector Laborato-
ries), 1: 100, for 10 min at room temperature. They are 
then washed with 0.05 M Tris buffered saline (twice, 3 
min each). It is very important to use rat-absorbed anti-
mouse IgG because most of these antisera will react with 
rat tissues, non-specifically. 
(3) The cells are incubated with a second layer of 
monoclonal Anti-Biotin (1:100) for 30 min at 37°C. 
Coverslips are then washed with 0.05 M Tris buffered 
saline (twice, 3 min each). 
(4) The cells are incubated with a second layer of 
biotinylated horse anti-mouse IgG (rat absorbed) 1: 100 
for 10 min at room temperature and washed with 0.05 
M Tris buffered saline (twice, 3 min each). 
(5) Finally, we incubate the cells with a 1:10 
dilution of peroxidase conjugated streptavidin (Dako, 
Catalog number P-397) for 5 min at room temperature. 
The cells are then washed with 0.05 M Tris buffered 
saline (twice). 
At this point, the nickel-intensifieddiaminobenzidine 
(DAB) is prepared by dissolving 0.45 g nickel ammoni-
um sulfate in 30 ml 0.05 M acetate buffer, adding 1 
diaminobenzidine tablet (Sigma Chemical, Catalog 
number D-5905). The solution is dissolved. Then we 
add 20 µl of 30 % hydrogen peroxide. The solution is 
filtered on a Whatman filter paper and then added to the 
cells for 6 min. The reaction product is blue-black. This 
reaction cannot be improved by longer times. There is 
a limited life and time-span of this solution. Therefore, 
to increase signal, we vary concentrations of the probe 
or other components of the detection protocol (see 
Combined immunocytochemistry and in situ hybridization 
1 
Figure l. A cluster of pituitary cells, one of which is 
dual-labeled for FSH-beta mRNA (black, arrows) and 
LR-beta antigens (gray, L). Note that the label for 
mRNA is in a linear pattern. The gray label for the LH 
antigens detects them throughout the cell except on the 
nucleus. Bar = 10 µm. Reproduced with permission 
from Childs et al. (1994). 
Discussion). 
After the diaminobenzidine step, the coverslips are 
washed with 0.05 M acetate buffer (twice), dehydrated, 
dried and mounted to glass slides, cell side up with 
Permount. A second square coverslip is mounted over 
the cells. Note: This DAB reaction product is dissolved 
in water soluble solutions and therefore cannot be used 
with water soluble mounting media or glycerol. There-
fore, use only organic solvent soluble mounting media 
with it. One can view the slides for a brief period 
mounted in glycerol, however eventually this will 
remove the reaction product. 
After the mRNA is detected with the blue-black 
peroxidase substrate, the cell can be further labeled by 
immunocytochemistry for its protein or antigen content. 
For this we use the dual-labeling protocol with contrast-
ing color peroxidase substrates. 
Applications of this technique to electron microscopic 
preparations 
We apply the above technique to the detection of 
mRNA at the electron microscopic level by leaving the 
dissociated pituitary cells in suspension (Childs et al., 
1990). Then, we spin the cells down at 900 rpm after 
each step. The gentle spinning is effective and creates 
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a pellet which must be resuspended in the new solution. 
After the diaminobenzidine step, the cells are exposed to 
1 % osmium tetroxide for 30 min at refrigerator tempera-
tures (2-4 °C). This fixes the membrane lipids and 
enhances the peroxidase reaction. The cell pellets are 
then embedded in Epon according to traditional electron 
microscopic methods. 
Dual-labeling for antigens 
After biotinylated ligands, mRNA or a first antigen 
is detected we use contrasting colored substrates and 
immunocytochemistry to detect an antigen (e.g., pitu-
itary hormone, growth factor, or c-fos.) The following 
shows an example of the protocol that detects the 
antigen. This allows us to identify the hormone content 
of the cell that expresses the mRNA. The basic dual-
labeling techniques have been published since 1983 
(Childs et al., 1983). They are outlined below. 
(1) Rinse coverslips with 0.05M Tris buffered saline 
(once). 
(2) Block again with 0.05 M Tris buffered saline + 
1 % bovine serum albumin (Sigma Chemical, Catalog 
number A-7638) for 15 min at room temperature. 
(3) Incubate with specific antisera to antigen in 
question (diluted 1:5000-1:50,000) for 30 min at 37°C. 
Wash coverslips with 0.05 M Tris buffered saline (three 
times). 
(4) Incubate with biotinylated goat anti-rabbit IgG 
(Vector Laboratories, Catalog number BA-1000) (This 
is made with 25 µl stock Biotinylated-IgG + 25 µl 
normal goat serum in 2 ml of buffer). Incubate for 20 
min at room temperature. Wash coverslips with 0.05 M 
Tris buffered saline (twice). 
(5) Incubate with 1:200 peroxidase conjugated 
streptavidin (DAKO, Catalog number P-397) for 20 min 
at room temperature. Wash coverslips with 0.05 M Tris 
buffered saline (twice). 
(6) To detect peroxidase, prepare orange-amber 
diaminobenzidine. Dissolve 1 Tris buffer tablet in 15 ml 
Millipore filtered water, add 1 diaminobenzidine tablet 
(Sigma Chemical, Catalog number D-5905) + 12 µl 
30 % hydrogen peroxide; filter on Wbatman filter paper 
and use immediately. Apply to cells for 5-7 min at 
room temperature. Wash coverslips with Millipore 
filtered water (three times). Dehydrate, dry and mount 
on slides with Permount. 
Note: diaminobenzidine is eventually washed out in 
water soluble mounting media, especially temporary 
mounting media like glycerol. Therefore, if another 
peroxidase substrate is used, that requires water soluble 
media, please store the slides dry and use glycerol 
ONLY for short periods of time. The best way to store 
the slides is to dehydrate the tissues and use permount. 
Table 2 lists Internet Uniform Resource Locator 
G.V. Childs 
Figure 2. Label for LR-beta mRNA on the surface of rough endoplasmic reticulum detected with a biotinylated cRNA 
probe and avidin peroxidase (arrows). Note that the secretory granules (g) remain unlabeled. Bar = 0.25 µm. 
(URL) links to courses, protocols and services in in situ 
hybridization. 
Results and Discussion 
The labeling for the mRNA is in dark patches or 
lines in the specific cell type. This can be confirmed by 
immunolabeling for the antigen in the same cell (Childs, 
1987, 1991a,b, 1992 a,b, 1994; Kaiser et al., 1992; Lee 
et al., 1993; Fan et al., 1995). However, there are 
clearly cells that contain only the antigen or only the 
mRNA (Childs et al., 1994). Thus, we have discovered 
cells in different stages of their secretory cycle (Childs 
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et al., 1994). 
Fig. 1 shows dual labeling for FSH mRNA and LH 
antigens (Childs et al., 1994). The cell in this figure 
expresses FSH mRNA in a black linear pattern, and 
Luteinizing hormone (LH) antigens, labeled orange. In 
black and white, the orange label is gray and fills the 
cell. 
Fig. 2 shows that, at the electron microscopic level, 
the label is associated with dilated profiles of rough 
endoplasmic reticulum (Childs et al., 1990). This field 
shows labeling for Luteinizing hormone beta subunit 
mRNA on dilated rough endoplasmic reticulum (RER) 
in a pituitary gonadotrope. Studies from our laboratory 
Combined immunocytochemistry and ill situ hybridization 
(Childs et al., 1990) show similar patterns of labeling 
for Follicle stimulating hormone mRNA. 
Troubleshooting this protocol 
The label is easy to detect in cells because of its 
density and linear or patchy pattern. However, it should 
not be mistaken for the metallic deposits sometimes seen 
in the cells (pseudoperoxidase activity). The label in 
cells that do not have amber label should be blue-black 
or a purplish blue. A steel-gray background over all the 
cells indicates background problems that should be 
eliminated (see below). 
The in situ hybridization fields should always be 
quantified. Furthermore comparisons should be made 
between single and dual-labeled preparations. One 
should count the percentages of labeled cells in fields 
exposed only to the single labeling protocol After one 
is confident of the percentages, one should then count 
the percentages of mRNA-bearing cells in the dual-
labeling protocol. They should match. To facilitate this 
comparison, we have developed a Lotus 1,2,3 or Exel 
Spreadsheet that automatically calculates these percentag-
es after we load in the raw counts (Childs et al., 1991 
a,b, 1994; Lee et al., 1993). We also compare percent-
ages of antigen bearing cells with those obtained through 
single labeling. These tests are vital to insure that the 
dual-labeling protocol does not interfere or add to the 
detected label for either mRNA or antigens. Controls 
run with the labeling protocol (see below) will also help 
test the specificity of the reaction. 
The labeling density for the mRNA (sensitivity) can 
be improved by adding another layer of anti-biotin and 
streptavidin. However, one runs the risk of higher 
background (McQuaid and Allan, 1992). Also, tests of 
different temperatures of hybridization may show an 
optimal temperature that promotes labeling. Finally, one 
can vary the concentration of probe from 0.1-100 ng/ml 
for example and the reaction should increase with 
increasing concentration (up to a plateau point). 
cRNA probes usually are more sensitive because 
they carry more biotin molecules/probe and they are 
longer. Yet, they are sticky and difficult to work with. 
They also require expertise in molecular biology tech-
niques for their production. Oligonucleotide probes may 
carry only one biotin although they can be engineered to 
carry more. Their sensitivity may also vary with the 
size and number of biotin molecules. Some low abun-
dance mRNAs may require cRNA probes for adequate 
detection. Nevertheless, for most of our studies, 
biotinylated oligonucleotide probes label expected 
populations of cells at concentrations of 1-100 ng/ml. 
One could also engineer several biotinylated probes 
directed against different parts of the mRNA transcript. 
This may increase sensitivity. All probes must react 
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with unique sequences, however, or specificity will be 
compromised. 
In our hands, this technique does not give high 
background. Usually the background is crystal clear and 
the unlabeled cells are difficult to see without the benefit 
of special optics. However, if there is background, it 
is usually seen as a steel gray (or light blue) deposit all 
over the field or cells. Also, it could be seen in dual-
labeled fields as light amber label all over the cells. In 
that case, one might suspect the second labeling proto-
col. However, both could be at fault. And, both should 
be checked. 
There are several ways to reduce background. 
First, one can remove one layer of the detection system 
for the mRNA (an anti-biotin and a anti-mouse lgG step) 
or dilute the components further. This should be done 
only if the signal is strong, however. Second, one can 
increase SSC washes, reducing the concentration to 
O. lX. This low salt provides high stringency conditions 
needed to wash out the non-specifically bound probes 
that may cause the background. This is especially a 
problem with the sticky cRNA probes. Caution must be 
given, however, to the possibility that the washes will 
wash out the probe attached in the specific hybrids. 
Finally, the use of different concentrations of the 
detecting reagents for the biotin (anti-biotin and strept-
avidin-peroxidase) will reduce background. If the signal 
is strong, one can dilute both and achieve optimal 
results. 
Controls 
We have controlled for interference during the dual 
labeling by eliminating either the complementary RNA 
probe from the first sequence or the specific antibody 
from the second sequence. In each case, the resulting 
labeling reflects only that which had the complete 
sequence. Thus, we have proved that the first detection 
protocol does not add to the label in the second (and visa 
versa). Furthermore, we have absorbed the specific anti-
body in the second sequence with its specific antigens. 
This has eliminated all second reactions and only the 
blue-black label for the mRNA is visible. This not only 
proves the specificity of the labeling, it proves that the 
amber diaminobenzidine does not cause the blue-black 
label to change color. In studies since 1983, we have 
shown that the blue-black diaminobenzidine is stable, as 
long as the second reaction is not prolonged (Childs et 
al., 1983). This is why the rapid ABC or DAKO 
immunoperoxidase kits are so valuable. If immuno-
labeling requires 48 hour incubation in antisera, one runs 
the risk of losing all detectable reaction product during 
the second incubation periods. Thus, immunoperoxidase 
kits with short incubation times should be chosen. 
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Summary 
To summarize, this protocol has been used success-
fully for the detection of mRNAs in tissue sections 
(McQuaid and Allan, 1992) and cell cultures (Fan et al., 
1995). It is preferred over the direct avidin detection 
systems because of its sensitivity and the fact that some 
avidin-containing kits produce high background. The 
anti-biotin sandwich method provides flexibility and 
enhancement potential along with a streptavidin solution 
that works at neutral pH and gives low background 
reactions. 
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Discussion with Reviewers 
Reviewer I: In many protocols, methanol treatment 
makes a variety of cultured cells sufficiently permeable 
to the probe. Your prehybridization protocol includes 
proteinase K treatment "to improve penetration (of 
probe) and remove associated proteins". Proteinase K is 
a very active, non-specific endopeptidase, at high 
concentration capable of degrading proteins into single 
amino-acids. Isn't the proteinase K treatment too hazard-
ous for epitopes to be detected in the same samples, 
after the hybridization step? 
Combined immunocytochemistry and in situ hybridiz.ation 
Author: That is an excellent question. The original 
technique was for use with cRNA probes to detect LH-
beta and FSH-beta mRNAs in rat pituitary cells. These 
large probes (300- 500 bp) required more intense 
deproteination. Therefore, we used the Proteinase K 
effectively to aid penetration. At the same time, we 
recognized the danger to the antigens to be detected in 
the immunolabeling protocol. Therefore, we tried 
fixation in 2 % glutaraldehyde for 30 min at room 
temperature before any of the hybridiz.ation steps. This 
fixative gives much stronger cross-linking than any 
formalin fixative because the glutaraldehyde has two 
aldehyde groups that can cross link amino acids (formal-
dehyde has only one group). 
We already knew that the anterior pituitary antigens 
were preserved well in glutaraldehyde-fixed tissues. 
Therefore, we were pleased when we discovered, in 
1987, that the in situ hybridiz.ation protocol with protein-
ase K did not destroy any of the pituitary antigens used 
to date. In fact, the major result was increased efficien-
cy in the reactions. All primary antisera dilutions were 
increased at least 2-fold. For example, in a recent 
experiment with Growth hormone detection, the optimal 
dilution of anti-GH after dual immunolabeling (two 
antigens) was 1:20,000-1:40,000. However, after in 
situ hybridiz.ation, the optimal dilution of anti-GH was 
1:70,000-1:80,000. These antigens are stored in gran-
ules and dilated rough endoplasmic reticulum and this 
may also be a factor in their recovery. Cytoplasmic 
antigens may be more labile and require less intense 
deproteination. 
Reviewer I: You have discussed reasons for high 
background associated with detection system for non-
radiolabeled probes. However, regardless of the probe 
labeling method, radioactive or non-radioactive, Jack of 
probe specificity remains one of them. In our hands (35S 
labeled riboprobes), the most effective way to improve 
signal to noise ratio, was to use a probe that in Northern 
analysis would detect a single band of a size matching 
the expected mRNA size. If this condition was fulfilled, 
the RN-ase treatment was found unnecessary. Do you 
think that evaluating specificity of biotin-labeled probes 
by Northern hybridiz.ation might be worth while? 
Author: Yes, all of our biotin-labeled cRNA probes 
(LH, FSH, follistatin, EGF) have been evaluated by 
either Northern Hybridiz.ation or RNase protection assay 
for specificity. They detected a single band. They were 
used to assay pituitary mRNAs in collaborative studies. 
Reviewer II: The author states that non-radioactive 
detection systems can be as sensitive as autoradiographic 
techniques with radiolabeled probes. How can one 
determine the sensitivity of the hybridiz.ation reaction 
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with biotinylated probes? 
Author: Actually, these techniques are not purely 
quantitative in that they do not allow one to detect 
amounts of DNA or mRNA in a cell. Thus, "efficient" 
is the operative word, rather than sensitivity. With our 
system, we use concentrations of cRNA probes for 
detection that are comparable to those used in autoradio-
graphic detection protocols. If the same enzyme tech-
niques are used in an in situ PCR reaction, the amplify-
ing effects of the enzyme substrates allow detection of as 
little as one copy of mRNA per cell. 
Reviewer II: How do various fixation conditions affect 
the sensitivity of the detection method. Is 2.5 % glutar-
aldehyde used for both light and electron microscopy 
and/or when performing a dual labeling experiment? 
Doesn't glutaraldehyde fixation abolish or reduce the 
antigenicity of endogenous proteins when performing a 
dual labeling experiment for both mRNA and endoge-
nous proteins.? 
Author: We always run comparative studies with any 
new antigen or mRNA and in every case have found 
increased, or equal detection efficiency when we used 
glutaraldehyde. This means that we can use lower 
concentrations of cRNA probes to get the same signal. 
We have compared results in a variety of fixatives, 
including para-formaldehyde, Bouin's, 10 % formalin 
and glutaraldehyde. We just completed another compar-
ison between formalin and 2 % glutaraldehyde and its 
effects on the detection of calcium channel mRNA in 
pituitary cells. The cells fixed in glutaraldehyde are 
much more intensely labeled. Furthermore, the peptide 
antigens are held in place by the stronger fixative and 
we have a much cleaner reaction in glutaraldehyde fixed 
tissues. Some of the larger glycoprotein antigens can be 
detected with much higher dilutions of antisera 
(1: 125,000) if para-formaldehyde is used, however the 
cell fixation is not optimal. Thus, we choose glutaralde-
hyde and these same antigens are detected with 
1:30,000-1:60,000 dilutions of their primary antisera. 
One trades efficiency (more dilute antisera) for optimal 
morphology. However, as stated above, we have never 
encountered loss of efficiency when detecting mRNA in 
glutaraldehyde-fixed tissues. Each new graduate student 
is asked to do the same comparison with a new mRNA 
and the conclusion has always been the same. 
Reviewer II: What is the major advantage of using a 
biotinylated detection method? What is the major 
disadvantage of using a biotinylated detection method? 
Author: The major advantage is the fact that one can 
achieve signal in a day, after as little as 2 hours of 
incubation in the cRN A probe. The longest protocols 
(with oligoprobes) are 1.5 days. It is also easily adapted 
G.V. Childs 
to a rapid immunolabeling technique, so in less than two 
days, one can detect the mRNA and the antigens. Also, 
no radioactive compounds are required to add to the 
growing waste. Finally, because the background is so 
low (absent), one need not view or depict the cells in 
dark field. Frequently, autoradiograms must be depicted 
in dark field, because the background grain level is so 
high in surrounding tissues. Finally, I have seldom seen 
autoradiograms where the labeling grains are well 
confined to the cells in question. It is impossible to 
detect regional labeling in such cells. Since we know 
that most cells are not filled with mRNA (100%), most 
of this is artifactual spread. In the case of the non-
radioactive systems, one can also get this spread, 
however, it can be more readily controlled. In the case 
of peroxidase, the labeling can be confined to the region 
of the mRNA, where it belongs (Figure 2). There are 
no real disadvantages to using any non-radioactive 
detection system, since it can be adapted to In situ PCR 
for the low abundance mRN As. If one has endogenous 
biotin, one can use the blocking kits supplied by Vector 
Laboratories. Also, there are blocking kits and reagents 
available for the enzymes in the detection systems. 
Reviewer II: Assuming that the mRN A is associated 
with cytoplasmic polyribosomes and/or with RER, what 
is the advantage of detecting mRNA hybrids at the 
ultrastructural level? What is the major advantage of 
being able to detect mRNA at the ultrastructural level, 
i.e., by electron microscopy. 
Author: In the pituitary, one cannot always differentiate 
the cell types accurately by morphology alone. Thus 
one needs a detection system that identifies the antigens 
within the granules and/or the mRNA on the rough 
endoplasmic reticulum. In the case of poorly differenti-
ated pituitary cells, one might have only polyribosomes 
and few storage granules. Such cells can only be 
identified by their content of mRNA for the particular 
hormone. Such cells are abundant among developing 
gonadotropes, for example. 
Reviewer II: How does one adapt this protocol for 
detection of mRNA in tissue sections? Are different 
fixation conditions used? 
Author: We have used frozen pituitary sections with 
biotinylated oligoprobes for A VP. We rapidly froze the 
small tissue blocks and cut the sections with a cryotome. 
Then, we fixed them in para-formaldehyde vapors. 
They were then detected with an avidin detection 
system. In this case, my student (Dr. Ping Wu) pre-
ferred to use streptavidin alkaline phosphatase. This 
was quite successful and her papers are cited in the 
reference list. We are now working on adapting the 
streptavidin alkaline phosphatase technique to a dual-
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labeling protocol and have bad some success with the 
use of immunoperoxidase as the detection system for the 
antigens. This protocol can be used as is for either cells 
in culture or frozen sections. 
Reviewer II: Where does one block for endogenous 
biotin, peroxidase, and/or alkaline phosphatase in the 
method described. 
Author: We have no endogenous biotin. We have been 
using biotin-avidin detection systems in the pituitary for 
over 15 years, and have never encountered any evidence 
of endogenous biotin. However, if it is a problem, one 
can use the blocking reagents supplied by Vector 
Laboratories. We also have been using peroxidase 
detection systems since 1972. We see pseudoperoxidase 
activity exhibited by red blood cells in our immuno-
labeling protocols. This can be eliminated by pre-
treatment with hydrogen peroxide. Interestingly, we 
never see this activity when running in situ hybridization 
protocols. Thus, something in our sequence must 
quench it. Our control fields are so crystal clear, it is 
difficult to find the cells without special optics. With 
regard to alkaline phosphatase, there are blocking kits 
and reagents available. However, our recent work has 
shown that they are unnecessary. A recent inadvertent 
proof of this happened when my technician accidentally 
left out the streptavidin alkaline phosphatase in the 
sequence that detected calcium channel mRNA. The 
cells were exposed to an extended time in the substrate 
solution. There was absolutely no reaction in these 
glutaraldehyde fixed cells. Finally, our current experi-
ments have been run on cells plated on silane coated 
slides with two wells indented in each slide. One of the 
wells is always a control, the other receives the biotinyl-
ated cRN A probe. We wash these slides in coplin jars, 
in the same solutions. Each slide is exposed to the same 
substrate solution. Not only are the controls for the 
single labeling protocol completely clean (showing no 
endogenous alkaline phosphatase), but the controls for 
the dual-labeling protocol remain clean (showing no 
endogenous peroxidase from the second protocol). The 
control and experimental fields on the same slide are as 
different as night and day, even if the experimental 
fields contain many intensely labeled cells. 
